Although telehealth has been historically underused due to technological barriers, high implementation costs, and limited clinician reimbursement,
1,2 it has become commonplace during the novel coronavirus disease 2019 (COVID-19) pandemic as a way of reducing viral spread while delivering clinical care. New federal legislation has accelerated telehealth adoption with improved reimbursement of telemedicine visits and temporary changes to videoconferencing regulations.
3,4 Given the rate of health system investment in telemedicine infrastructure during the COVID-19 pandemic, continued growth and widespread adoption are expected.